Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Thai State Council Takes Up Compulsory Licensing Issue

This article was originally published in PharmAsia News

Executive Summary

Thailand's Council of State has taken up the issue of the whether the Public Health Ministry's policy of imposing compulsory licensing on foreign drug makers is legal. Sanofi Aventis of France, seeking to protect the patent on its Taxotere (doxetaxel) breast cancer drug, earlier petitioned the government to review the ministry's CL policy, which the company said violates two articles of the nation's Patent Act. The Commerce Ministry, given authority over such issues by the act, sought a ruling by the Council of State. The AIDS Access Foundation has urged the council to keep the CL policy in place. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts